Deutsch English Français

Contact

EP0702084

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0702084

EP0702084 - Recombinant retroviruses [Right-click to bookmark this link]
Status	Patent revoked Status updated on 22.05.2009 Database last updated on 07.10.2024
Most recent event Tooltip	19.06.2009	Lapse of the patent in a contracting state	published on 22.07.2009 [2009/30]
Applicant(s)	For all designated states Oxford Biomedica (UK) Ltd Medawar Center Robert Robinson Avenue Oxford Science Park Oxford, OX4 4GA / GB
	[2006/09]
Former [1997/43]	For all designated states CHIRON CORPORATION 4560 Horton Street Emeryville, California 94608 / US
Former [1996/23]	For all designated states CHIRON VIAGENE, INC. 4560 Horton Street Emeryville, California 94608 / US
Former [1996/12]	For all designated states VIAGENE, INC. 11055 Roselle Street San Diego, California 92121 / US
Inventor(s)	01 / Gruber, Harry E. 13083 Maritime Place San Diego, California 92130 / US
	02 / Jolly, Douglas J. 277 Hillcrest Drive Leucadia, California 92024 / US
	03 / Respess, James G. 4966 Lamont Street San Diego, California 92109 / US
	04 / Laikino, Paul K. 12433 Caminito Mira Del Mar San Diego, California 92130 / US
	[1996/15]
Representative(s)	Mallalieu, Catherine Louise, et al D Young & Co LLP 120 Holborn London EC1N 2DY / GB
	[N/P]
Former [2004/48]	Mallalieu, Catherine Louise, et al D. Young & Co. 120 Holborn London EC1N 2DY / GB
Former [2003/02]	Hallybone, Huw George, et al Carpmaels and Ransford, 43 Bloomsbury Square London WC1A 2RA / GB
Former [1997/09]	Goldin, Douglas Michael, et al J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB
Former [1996/15]	Brasnett, Adrian Hugh, et al J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB
Former [1996/12]	Gowshall, Jonathan Vallance FORRESTER & BOEHMERT Franz-Joseph-Strasse 38 D-80801 München / DE
Application number, filing date	95115441.8	21.03.1989
	[1996/12]
Priority number, date	US19880170515	21.03.1988 Original published format: US 170515
	[1996/12]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP0702084
	Date:	20.03.1996
	Language:	EN
	[1996/12]
	Type:	B1 Patent specification
	No.:	EP0702084
	Date:	22.12.1999
	Language:	EN
	[1999/51]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	17.01.1996
Classification	IPC:	C12N15/86, C12N9/50, C12N15/11, C12N9/12, C07K14/73	[1996/12]
	CPC:	C12N15/86 (EP); A61K38/2013 (EP); A61K38/217 (EP); A61P25/28 (EP); A61P3/08 (EP); A61P3/10 (EP); (+) A61P31/12 (EP); A61P31/18 (EP); A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP); A61P9/00 (EP); C07K14/005 (EP); C07K14/70514 (EP); C12N7/00 (EP); C12Q1/02 (EP); A01K2217/05 (EP); A61K2039/5256 (EP); A61K2039/53 (EP); A61K2039/57 (EP); A61K38/00 (EP); A61K48/00 (EP); C12N2740/10043 (EP); C12N2740/13022 (EP); C12N2740/16022 (EP); C12N2740/16023 (EP); C12N2740/16043 (EP); C12N2740/16122 (EP); C12N2740/16222 (EP) (-)
Designated contracting states	AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE [1996/12]
Title	German:	Rekombinante Retroviren	[1996/12]
	English:	Recombinant retroviruses	[1996/12]
	French:	Rétrovirus recombinants	[1996/12]
Examination procedure	29.09.1995	Examination requested [1996/12]
	22.01.1997	Despatch of a communication from the examining division (Time limit: M06)
	19.09.1997	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	12.11.1997	Reply to a communication from the examining division
	07.04.1998	Despatch of a communication from the examining division (Time limit: M04)
	13.08.1998	Reply to a communication from the examining division
	03.02.1999	Despatch of communication of intention to grant (Approval: No)
	25.03.1999	Observations by third parties
	10.06.1999	Despatch of communication of intention to grant (Approval: later approval)
	28.06.1999	Observations by third parties
	27.08.1999	Communication of intention to grant the patent
	06.09.1999	Fee for grant paid
	06.09.1999	Fee for publishing/printing paid
Parent application(s) Tooltip	EP89105059.3 / EP0334301
Opposition(s)	Opponent(s)	01 20.09.2000 08.12.2004 WITHDRAWN Fielding, Michael Terry Upham Street, Lower Upham Hampshire, SO32 1JA / GB Opponent's representative White, Martin Paul Marks & Clerk LLP Commonwealth House 1-19 New Oxford Street London WC1A 1LW / GB
		02 21.09.2000 20.11.2000 ADMISSIBLE COHEN, Jacques 139, rue de Courlancy 51100 REIMS / FR Opponent's representative Becker, Philippe Cabinet Becker & Associés 25 Rue Louis Le Grand 75002 Paris / FR
		03 22.09.2000 20.10.2000 ADMISSIBLE Novartis AG 4002 Basel / CH Opponent's representative Kassow, Anders Novartis Pharma AG Patent Department 4002 Basel / CH
		[N/P]
	Former [2008/39]
	Opponent(s)	01 20.09.2000 08.12.2004 WITHDRAWN Fielding, Michael Terry Upham Street, Lower Upham Hampshire, SO32 1JA / GB Opponent's representative White, Martin Paul Lloyd Wise, Tregear & Co. Commonwealth House 1-19 New Oxford Street London WC1A 1LW / GB
		02 21.09.2000 20.11.2000 ADMISSIBLE COHEN, Jacques 139, rue de Courlancy 51100 REIMS / FR Opponent's representative Becker, Philippe Cabinet Becker & Associés 25, rue Louis Le Grand 75002 Paris / FR
		03 22.09.2000 20.10.2000 ADMISSIBLE Novartis AG 4002 Basel / CH Opponent's representative Kassow, Anders Novartis Pharma AG Patent Department 4002 Basel / CH
	Former [2008/36]
	Opponent(s)	01 20.09.2000 08.12.2004 WITHDRAWN Fielding, Michael Terry Upham Street, Lower Upham Hampshire, SO32 1JA / GB Opponent's representative White, Martin Paul Lloyd Wise, Tregear & Co. Commonwealth House 1-19 New Oxford Street London WC1A 1LW / GB
		02 21.09.2000 20.11.2000 ADMISSIBLE COHEN, Jacques 139, rue de Courlancy 51100 REIMS / FR Opponent's representative Becker, Philippe Cabinet Becker & Associés 35, rue des Mathurins 75008 Paris / FR
		03 22.09.2000 20.10.2000 ADMISSIBLE Novartis AG 4002 Basel / CH Opponent's representative Kassow, Anders Novartis Pharma AG Patent Department 4002 Basel / CH
	Former [2006/11]
	Opponent(s)	01 20.09.2000 08.12.2004 WITHDRAWN Fielding, Michael Terry Upham Street, Lower Upham Hampshire, SO32 1JA / GB Opponent's representative White, Martin Paul Lloyd Wise, Tregear & Co. Commonwealth House 1-19 New Oxford Street London WC1A 1LW / GB
		02 21.09.2000 20.11.2000 ADMISSIBLE COHEN, Jacques 139, rue de Courlancy 51100 REIMS / FR Opponent's representative Becker, Philippe Cabinet Becker & Associés 35, rue des Mathurins 75008 Paris / FR
		03 22.09.2000 20.10.2000 ADMISSIBLE Novartis AG 4002 Basel / CH Opponent's representative Gros, Florent Novartis AG Corporate Intellectual Property, Patent & Trademark Department CH 4002 Basel / CH
	Former [2005/05]
	Opponent(s)	01 20.09.2000 08.12.2004 WITHDRAWN Fielding, Michael Terry Upham Street, Lower Upham Hampshire, SO32 1JA / GB Opponent's representative White, Martin Paul Lloyd Wise, Tregear & Co. Commonwealth House 1-19 New Oxford Street London WC1A 1LW / GB
		02 21.09.2000 20.11.2000 ADMISSIBLE COHEN, Jacques 139, rue de Courlancy 51100 REIMS / FR Opponent's representative Becker, Philippe Cabinet Becker & Associés 35, rue des Mathurins 75008 Paris / FR
		03 22.09.2000 20.11.2000 ADMISSIBLE Novartis AG 4002 Basel / CH Opponent's representative Gros, Florent Novartis AG Corporate Intellectual Property, Patent & Trademark Department CH 4002 Basel / CH
	Former [2000/48]
	Opponent(s)	01 20.09.2000 Fielding, Michael Terry Upham Street, Lower Upham Hampshire, SO32 1JA / GB Opponent's representative White, Martin Paul Lloyd Wise, Tregear & Co. Commonwealth House 1-19 New Oxford Street GB-London WC1A 1LW / GB
		02 21.09.2000 COHEN, Jacques 139, rue de Courlancy 51100 REIMS / FR Opponent's representative Becker, Philippe Cabinet Becker & Associés 10, rue de Milan 75009 Paris / FR
		03 22.09.2000 Novartis AG 4002 Basel / CH Opponent's representative Gros, Florent Novartis AG Corporate Intellectual Property, Patent & Trademark Department CH 4002 Basel / CH
	Former [2000/46]
	Opponent(s)	01 20.09.2000 WITHDRAWN Fielding, Michael Terry Upham Street, Lower Upham Hampshire, SO32 1JA / GB Opponent's representative White, Martin Paul Lloyd Wise, Tregear & Co. Commonwealth House 1-19 New Oxford Street GB-London WC1A 1LW / GB
		02 21.09.2000 COHEN, Jacques 139, rue de Courlancy 51100 REIMS / FR Opponent's representative Becker, Philippe Cabinet Becker & Associés 10, rue de Milan 75009 Paris / FR
		03 22.09.2000 Novartis AG 4002 Basel / CH
	23.11.2000	Invitation to proprietor to file observations on the notice of opposition
	28.09.2001	Reply of patent proprietor to notice(s) of opposition
	23.02.2006	Date of oral proceedings
	24.05.2006	Despatch of minutes of oral proceedings
	25.05.2006	Despatch of a communication from the opposition division (Time limit: M04)
	02.10.2006	Reply to a communication from the opposition division
	20.08.2007	Despatch of a communication from the opposition division (Time limit: M02)
	09.02.2009	Despatch of communication that the patent will be revoked
	19.02.2009	Legal effect of revocation of patent [2009/26]
Request for further processing for:	12.11.1997	Request for further processing filed
	12.11.1997	Full payment received (date of receipt of payment) Request granted
	26.11.1997	Decision despatched
Fees paid	Renewal fee
	29.09.1995	Renewal fee patent year 03
	29.09.1995	Renewal fee patent year 04
	29.09.1995	Renewal fee patent year 05
	29.09.1995	Renewal fee patent year 06
	29.09.1995	Renewal fee patent year 07
	26.02.1996	Renewal fee patent year 08
	24.02.1997	Renewal fee patent year 09
	23.02.1998	Renewal fee patent year 10
	04.03.1999	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]FR2559159 (INST NAT SANTE RECH MED [FR]) [X] 1,2 * example V *;
		[XD]EP0243204 (CETUS CORP [US], et al) [XD] 1-5,11 * the whole document *;
		[PX]FR2606030 (PASTEUR INSTITUT [FR]) [PX] 1,2* page 8 - page 9 *;
		[X] - J.G.IZANT ET AL., "Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA", SCIENCE, LANCASTER, PA US, (19850726), vol. 229, pages 345 - 352 [X] 1,2,7,10 * figure 1 *
		[XD] - R.TELLIER ET AL., "New strategies for AIDS therapy and prophylaxis", NATURE, LONDON GB, (19851205), vol. 318, page 414 [XD] 1,2,7,10 * the whole document *
		[X] - J.T.HOLT ET AL., "Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, WASHINGTON US, vol. 83, doi:doi:10.1073/pnas.83.13.4794, pages 4794 - 4798, XP002121078 [X] 1-3,7 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.83.13.4794

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p